People

Ralph Minter

Antibody and biologics discovery specialist with experience developing therapeutic platforms and clinical-stage drugs at Cambridge Antibody Technology, MedImmune, AstraZeneca and Alchemab.

Roles

Forth Therapeutics

Chief Technology Officer

Current